935D52C1DA97B8FBBE11F0D6CB6921F1883819490D7C8B1C0444F1C88558EDC23D8C20289E4EE1517F839A0B43350243

Systematic vaccination of individuals at risk of exposure to the virus has been the main method of controlling the morbidity and mortality associated with hepatitis B. The first hepatitis B vaccine was manufactured by the purification and inactivation of HBsAg obtained from the plasma of chronic hepatitis B virus carriers. The vaccine is now produced by recombinant DNA techniques and expression of the S isoform in yeast cells. The pre-S region do not seem to induce strong enough antigenic response.

Source:http://purl.uniprot.org/SHA-384/935D52C1DA97B8FBBE11F0D6CB6921F1883819490D7C8B1C0444F1C88558EDC23D8C20289E4EE1517F839A0B43350243

Download in:

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	uniprot:Biotechnology_Annotation
rdfs:comment	Systematic vaccination of individuals at risk of exposure to the virus has been the main method of controlling the morbidity and mortality associated with hepatitis B. The first hepatitis B vaccine was manufactured by the purification and inactivation of HBsAg obtained from the plasma of chronic hepatitis B virus carriers. The vaccine is now produced by recombinant DNA techniques and expression of the S isoform in yeast cells. The pre-S region do not seem to induce strong enough antigenic response.